What is Zacks Research’s Estimate for SMG Q4 Earnings?

The Scotts Miracle-Gro Company (NYSE:SMGFree Report) – Research analysts at Zacks Research lowered their Q4 2026 EPS estimates for shares of Scotts Miracle-Gro in a report released on Monday, August 17th. Zacks Research analyst Team now expects that the basic materials company will post earnings of ($2.15) per share for the quarter, down from their prior forecast of ($1.95). The consensus estimate for Scotts Miracle-Gro’s current full-year earnings is $4.41 per share. Zacks Research also issued estimates for Scotts Miracle-Gro’s Q1 2027 earnings at ($0.74) EPS, Q4 2027 earnings at ($1.63) EPS and Q1 2028 earnings at ($0.73) EPS.

Scotts Miracle-Gro (NYSE:SMGGet Free Report) last released its quarterly earnings results on Wednesday, July 29th. The basic materials company reported $2.82 earnings per share for the quarter, beating analysts’ consensus estimates of $2.48 by $0.34. Scotts Miracle-Gro had a net margin of 2.19% and a negative return on equity of 81.90%. The company had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same period last year, the firm earned $2.59 earnings per share. The firm’s revenue was up 1.1% on a year-over-year basis.

Other equities analysts also recently issued reports about the stock. Wells Fargo & Company boosted their price target on shares of Scotts Miracle-Gro from $74.00 to $77.00 and gave the stock an “overweight” rating in a report on Thursday, July 30th. Wall Street Zen lowered Scotts Miracle-Gro from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. UBS Group increased their price target on Scotts Miracle-Gro from $70.00 to $78.00 and gave the stock a “neutral” rating in a research note on Thursday, July 30th. Jefferies Financial Group reiterated a “buy” rating and set a $79.00 target price on shares of Scotts Miracle-Gro in a research report on Wednesday, April 29th. Finally, Stifel Nicolaus lifted their price objective on shares of Scotts Miracle-Gro from $75.00 to $76.00 and gave the company a “buy” rating in a research note on Monday, August 3rd. Three investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Scotts Miracle-Gro currently has an average rating of “Hold” and a consensus target price of $75.40.

Check Out Our Latest Stock Report on SMG

Scotts Miracle-Gro Stock Up 0.5%

Shares of NYSE SMG opened at $59.48 on Wednesday. The company has a market capitalization of $3.46 billion, a PE ratio of 51.72 and a beta of 1.82. The stock’s 50 day moving average price is $65.85 and its 200-day moving average price is $64.26. Scotts Miracle-Gro has a twelve month low of $52.00 and a twelve month high of $75.34.

Scotts Miracle-Gro Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Friday, August 21st will be issued a dividend of $0.66 per share. The ex-dividend date is Friday, August 21st. This represents a $2.64 annualized dividend and a yield of 4.4%. Scotts Miracle-Gro’s dividend payout ratio is currently 229.57%.

Insider Activity at Scotts Miracle-Gro

In other Scotts Miracle-Gro news, Director Stephen L. Johnson sold 1,171 shares of the stock in a transaction that occurred on Thursday, July 30th. The stock was sold at an average price of $68.32, for a total value of $80,002.72. Following the completion of the sale, the director owned 30,179 shares in the company, valued at approximately $2,061,829.28. This trade represents a 3.74% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Mark D. Kingdon sold 831 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $61.65, for a total transaction of $51,231.15. Following the completion of the sale, the director owned 10,827 shares of the company’s stock, valued at $667,484.55. This trade represents a 7.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 32,002 shares of company stock worth $2,154,734 in the last three months. 24.40% of the stock is owned by insiders.

Institutional Investors Weigh In On Scotts Miracle-Gro

A number of hedge funds have recently added to or reduced their stakes in the stock. Public Employees Retirement System of Ohio bought a new position in shares of Scotts Miracle-Gro during the 2nd quarter valued at $1,323,000. Ancora Advisors LLC bought a new stake in shares of Scotts Miracle-Gro in the second quarter worth $272,000. Compass Financial Management LLC purchased a new stake in Scotts Miracle-Gro during the second quarter valued at $2,162,000. Madison Asset Management LLC bought a new position in Scotts Miracle-Gro in the second quarter valued at about $7,163,000. Finally, Trust Co. of Vermont bought a new position in Scotts Miracle-Gro in the second quarter valued at about $175,000. 74.07% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Scotts Miracle-Gro

Here are the key news stories impacting Scotts Miracle-Gro this week:

  • Positive Sentiment: Zacks Research raised its estimates for several profitable periods, including FY2026 EPS to $4.43 from $4.30, FY2027 EPS to $4.60 from $4.50, and FY2028 EPS to $4.95 from $4.73. Estimates for Q2 2027, Q2 2028 and Q3 2028 were also increased, suggesting analysts see potential for longer-term earnings improvement.
  • Neutral Sentiment: Scotts and the Columbus Crew hosted an Ohio 4-H mowing clinic at ScottsMiracle-Gro Field. The community and brand-building event highlights Scotts’ turfgrass expertise but is unlikely to have a material near-term effect on earnings. Columbus Crew and Scotts Host Ohio 4-H Youth for First-ever Mowing Clinic at ScottsMiracle-Gro Field
  • Negative Sentiment: Zacks Research trimmed multiple near-term forecasts: Q4 2026 EPS was lowered to a loss of $2.15 from $1.95, Q1 2027 to a loss of $0.74 from $0.73, Q4 2027 to a loss of $1.63 from $1.62, and Q1 2028 to a loss of $0.73 from $0.72. Although the reductions are small, they may weigh on sentiment because they point to somewhat weaker expectations during upcoming seasonal loss periods.

About Scotts Miracle-Gro

(Get Free Report)

Scotts Miracle-Gro Company is a leading developer, manufacturer and distributor of consumer lawn and garden products. The firm serves both retail and professional customers through an array of branded offerings that include lawn fertilizers, grass seed, pest and disease control solutions, plant foods and specialty products for indoor and outdoor gardening. Its portfolio spans well-known names such as Scotts®, Miracle-Gro®, Ortho® and various hydroponic and specialty garden brands.

Headquartered in Marysville, Ohio, the company traces its roots to O.M.

Featured Articles

Earnings History and Estimates for Scotts Miracle-Gro (NYSE:SMG)

Receive News & Ratings for Scotts Miracle-Gro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scotts Miracle-Gro and related companies with MarketBeat.com's FREE daily email newsletter.